and January 2012. Medical records of patients who were followed for less than 6 months were excluded. The diagnosis of West syndrome was based on the presence of epileptic spasms, along with electroencephalographic (EEG) findings of hypsarrhythmia or its variants. Hypsarrhythmia was defined as EEG showing highvoltage chaotic slow waves intermixed with spike and sharp wave discharges. Modified hysparrythmia was defined in presence of any of the following: increased interhemispheric synchronizationconsistent voltage asymmetries; consistent focus of abnormal discharge; episodes of generalized/regional or lateralized voltage attenuation; or primarily high-voltage bilaterally asynchronous slow wave activity. 7 
Baseline clinical data
The following data were collected from the case records: sex, age of onset of infantile spasms, age at diagnosis, and the type of spasms. The average number of spasms per cluster and number of clusters per day was recorded. The frequency of spasms was noted from parent-maintained seizure dairy or parental recall during visits. History of sleep problems, feeding problems, and presence of repeated chest infections was also noted. The 'lag time' was defined as the time from initial observation of spasms to diagnosis.
History of perinatal events, developmental milestones and relevant family events was recorded. The diagnosis of birth asphyxia was considered when the delayed cry at birth was followed with features of neonatal encephalopathy. Physical examination findings suggestive of cerebral palsy, microcephaly, presence of neurocutaneous markers, dysmorphism, and organomegaly were documented.
Investigations
The results of EEG and neuroimaging (CT/MRI) were noted. Computed tomography (CT) scan was the initial investigation in children where there was a clear history suggestive of perinatal insult, postnatal meningitis, or encephalitis. Magnetic resonance imaging (MRI) was performed in all the other cases, and in cases where the CT scan was normal. Children with clinical suspicion of metabolic disorders (a history of parental consanguinity, prior affected siblings, unexplained vomiting, intermittent worsening of symptoms, recurrent episodes of lethargy, altered sensorium, or ataxia or hepatosplenomegaly on examination) or no obvious etiology on clinical evaluation and neuroimaging were screened for inherited metabolic disorders based on reports of arterial blood gas, blood lactate, blood ammonia, urine ketones, and blood tandem mass spectrometry. Based on the etiology, West syndrome was classified as symptomatic (known etiology) or cryptogenic (unknown etiology).
Treatment protocol
Available treatment options included prednisolone, pyridoxine, sodium valproate, vigabatrin, nitrazepam, topiramate, and levetiracetam. Treatment options varied according to the affordability of the treatment for the patient and associated infection and malnutrition. Prednisolone and sodium valproate are available free from the hospital. The usual protocol at our center is to start with a trial of pyridoxine (15 mg/kg/day) for 3-7 days (Fig. 1) . In pyridoxine unresponsive patients, oral prednisolone (2 mg/kg/ day) was given. Patients who were severely malnourished or had evidence of active tuberculosis were not administered steroids. These patients were treated with vigabatrin. Those who failed steroids were also started on vigabatrin if the parents could afford it. Otherwise, the treatment options included sequential trials of sodium valproate, nitrazepam, topiramate, and levetiracetam (Fig. 1) . The treatment received by the patient and the response in terms of spasm reduction or cessation was noted. The treatment protocol was modified if the drugs in next sequence had already been tried. Treatment response was classified as spasm cessation when there was a complete cessation of spasms, partial response when >50% improvement was observed, and poor response when there was <50% improvement; two weeks after starting the drug.
Follow-up records
Records of follow-up were studied to determine the response to treatment, any evidence of relapse, and progression to other seizure types. EEG was repeated in patients who developed a relapse or progressed to have other seizure types and in those with spasm cessation to document resolution of hypsarrhythmia. An EEG was also repeated if the patient developed a relapse or progressed to have other seizure types. The final outcome was considered favorable when there was a complete spasm cessation for at least 6 months without relapse or progression to other seizure types. The presence of favorable outcome was studied in relation to the etiology and clinical variables at presentation.
Analysis
The data were entered by two investigators (JSK and SS) into separate Microsoft Excel sheets, the sheets were compared, and any inconsistency was cross-checked with the original data. Categorical variables were presented as proportions; their association with the final outcome was compared using the chisquare test. Continuous variables were presented as mean (SD) and their associations with the final outcome were compared using the unpaired Student's t-test. The level of significance was assumed at 5%. Multivariate logistic regression was applied keeping the final outcome (favorable outcome) as the dependent variable. Independent variables considered in model included; age at onset (in months), time lag to treatment (in months), gender, history of neonatal intensive care unit (NICU) stay (yes/no), and etiology. The statistical analysis was done using SPSS 17.0 version.
Results

Clinical and demographic profile
Records of 148 children were finally analyzed (records identified: 156; excluded for inadequate follow up: 8) ( Table 1) . The age at onset of spasms ranged from 1 month to 30 months [mean 5.3 (4.6) months]. The mean (SD) age at diagnosis of West syndrome was 13.1 (7.2) months. The mean (SD) lag time to treatment was 7.9 (7.4) months. There was a male preponderance [n = 120 (81.1%)] in our study. The median duration of follow-up was 12 months (range 6-43 months). Developmental delay prior to the onset of spasms was present in 137 (92.5%) patients. EEG findings were compatible with hypsarrhythmia in 63 (42.4%) children; and with modified hypsarrythmia in the rest (57.6%).
Almost two-thirds of the children had flexor spasms with the rest having mixed or extensor spasms. The enrolled children had an average 10 clusters per day, with each cluster having 5 spasms. Relationship of spasms with the sleep-wake cycle was observed in 108 (72.9%) children. There were 13 (8.4%) children who were small for gestational age.
Etiology
In our study, the majority of the children were symptomatic [122 (82.4%)]; etiology could not be ascertained in the rest. Perinatal brain injury was the leading cause of West syndrome, seen in 81 children (66.3%) ( Table 2 ). Among the perinatal causes, birth asphyxia was the predominant. Neonatal sepsis/meningitis (13), neonatal hypoglycemia (5), prematurity (3), kernicterus (1), and perinatal stroke (1) were the other perinatal etiologies. Postnatal causes included meningitis and meningoencephalitis in 14 children. Prenatal causes included malformations of cortical development (5), intrauterine infections (2), tuberous sclerosis (1), and inherited metabolic disorders (2).
Treatment response
Drugs used in our study for treatment of children with West syndrome included pyridoxine (135), prednisolone (122), sodium valproate (110), vigabatrin (47), nitrazepam (27), topiramate (16) , and levetiracetam (9) . The response to treatment is depicted in Table 3 . Complete spasm cessation occurred in only one patient with pyridoxine. With the use of oral prednisolone, complete spasm cessation was observed in 31 (25.4%), while an additional 31.9% showed a partial response. Eighteen (16%) children achieved complete spasm cessation with sodium valproate, and 13 (27.6%) with vigabatrin. A repeat EEG could be obtained in 65 children with complete spasm cessation; 19 were normal and hypsarrhythmia persisted in 12 children. Hypsarrhythmia resolved with presence of background and other epilepitiform abnormalities in 34 children.
Factors predicting favorable outcome
Forty-five children had a favorable outcome. The age at onset, gender, or lag time for treatment initiation was not found to have any significant role in predicting a favorable outcome (Table 4) . 
Discussion
This was a large retrospective study of children with West syndrome conducted in resource-constrained settings of a developing country. We observed that symptomatic West syndrome formed a major group (82%) and that was significantly associated with an unfavorable outcome. Age at onset, etiology, and lag time in treatment did not effect the final outcome. Our study highlights the clinical spectrum, treatment response, and predictors of outcome in children with West syndrome, hence providing a developing country perspective. The challenges faced in our setting include delayed presentation; inability for patients to procure expensive medications like ACTH, vigabatrin, and levetiracetam; and difficulty in admitting the patient to the inpatient setting for ACTH treatment owing to overcrowding in the hospital and the risk of developing cross infections.
The mean age at onset of infantile spasms (5.3 months) was comparable to experience at other centers. [8] [9] [10] Mean lag time in treatment initiation in most of the Western studies varies between 25 and 45 days. [8] [9] [10] The lag time was significantly higher in our study, likely owing to the health-seeking behavior of parents; lack of awareness on this ailment among the pediatricians; and use of inappropriate antiepileptics such as phenobarbitone, phenytoin, and carbamazepine. These are acknowledged as lacunae in the treatment of children in the developing countries. 3,4 Surprisingly, we did not find any association of the lag time with the final outcome. This is in contrast to earlier studies, that demonstrated better long term outcome in children with early treatment inititation. 6, 11 Improving awareness of clinicians and parents about infantile spasms and helping them differentiate it from abdominal colic or startle reflex might reduce the lag time. We acknowledge that the relatively small sample size of our study could also probably influence the impact of lag time to treatment on the final outcome. We found a striking male preponderance in our study, probably owing to gender-biased referral and treatment-seeking behavior of parents. This gender bias is well rooted in the traditional culture of the Indian society where male children are brought to medical attention more frequently and females are neglected. These findings are similar to other studies from the Indian subcontinent. 3, 4 We observed that 92.5% of children had developmental delay preceding the onset of spasms. In our study, almost twothirds of children were microcephalic and half had comorbid spastic quadriplegic cerebral palsy. These findings are consistent with previous reports. 3,4,12 However, we did not observe the effect of these parameters on the final outcome. High rates of comorbidities such as cerebral palsy, microcephaly, vision and hearing impairment, and feeding difficulties as sequelae of perinatal insults are additional problems in children with West syndrome in our scenario. The proportion of symptomatic cases is higher in our scenario as compared to Western data. In the United Kingdom infantile spasms study, a known etiology could be demonstrated in 61% of the cases, whereas in our study, 82% of the patients had a known etiology. 13 The etiological profile in our study was also considerably different from the West. The most common cause of was a perinatal brain injury, especially perinatal asphyxia. In contrast, prenatal causes which include cortical malformations, neurocutaneous syndromes, and genetic-metabolic disorders are the predominant etiologies in the West. [13] [14] [15] High incidence of perinatal asphyxia in our study setting could be attributed to lack of antenatal care, high rates of home delivery, delivery by unskilled workers, delay in treatment initiation, and a poor referral system. Improvement in the maternal and neonatal health services may help in reducing the incidence of West syndrome in developing countries. We found a spasm cessation rate of 25.4% with oral prednisolone. In the doses used (2 mg/kg/day), oral prednisolone has been shown to be less effective as compared to ACTH. Spasm freedom rates ranging from 25% to 33% have been found at this dose, compared to 70% response rate with ACTH. [16] [17] [18] Our response rates 19 The risks of using the high-dose steroid in developing countries like India, especially infections, have to be balanced with the advantages. A randomized trial comparing the usual dose (2 mg/kg/day) and high dose (4 mg/kg/day) in children with newly diagnosed West syndrome is now in progress at our center (Clinical Trials.Gov identifier NCT01575639). As vigabatrin is expensive, it was offered only to those patients who failed steroids and were able to afford it. In our study, out of 47 such patients, 13 had spasm freedom accounting to the responder rate of 27.6%. This is lower than the 54% response rate reported in the literature, 19 but this is likely due to the delay in treatment initiation and use as a second-line agent. Other drugs such as sodium valproate, topiramate, and nitrazepam showed modest efficacy ranging from 16% to 19%, which is lower than previous reported literature, [21] [22] [23] but could be accounted for by the fact that these drugs were used as second-and third-line agents, which might have resulted in reduced efficacy. Pyridoxine was also not found to be a useful agent, contrary to reports from Japan, where this agent has been used extensively for the treatment of infantile spasms. 24 Only one child in our cohort was pyridoxine responsive. Hence, we consider that the pyridoxine drug trial may not be warranted in our setting. Perhaps the response may improve with higher doses or the use of other formulations such as pyridoxal phosphate. 25 In our study, we preferred the term ''favorable outcome'' instead of treatment success and treatment failure, considering that EEG evidence of hypsarrhythmia might persist despite cessation of clinical spasms. Definition of favorable outcome was more clinically relevant and parent-centered.
The limitations of the study include the absence of long-term video-EEG monitoring for assessing treatment outcomes and lack of long-term follow-up. Lack of long-term follow-up is difficult in our study setting owing to the large proportion children who belong to the migrant population in Delhi. Also, we did not objectively assess the developmental outcome. Another limitation to be considered while assessing treatment outcomes is that the natural history of spasms must be taken into account, with the possibility of spontaneous remission. This is all the more important in our scenario with delayed presentation. However, despite these shortcomings, the data of this large number of patients gives us an insight into the challenges faced in the management of West syndrome in resource constrained settings.
In conclusion, we describe the clinico-etiological profile and treatment outcome of children with West syndrome in a developing country scenario. The commonest etiology was perinatal brain injury, especially birth asphyxia. There was a prolonged lag time between the onset of spasms and initiation of treatment. Symptomatic etiology was associated with an unfavorable outcome.
